Study Contributors

COVIDRIVE’s Study Contributors network consists of hospital and primary care study sites from 12 European countries: Austria, Belgium, Croatia, Finland, France, Germany, Iceland, Italy, Netherlands, Poland, Romania, Spain and the United Kingdom.

COVIDRIVE Study Contributors network (as of 4th of February 2022).

COVIDRIVE is open to include new study sites in its European network. For more information on how to join COVIDRIVE, please see section “Participate

  • BREATHE consortium (United Kingdom) 
  • Centro Interuniversitario per la Ricerca sull’Influenza e le altre Infezioni Trasmissibili (CIRI-IT, Italy)
  • COVIREIVAC hospital network, France
  • Finnish Institute for Health and Welfare (THL, Finland)
  • Fisabio VAHNSI hospital network (Spain)
  • German Centre for Infection Research (DZIF hospital network, Germany)
  • GZIM and Forum Impfen Primary care networks (Germany)
  • Hospital Universitario de Salamanca (Spain)
  • Hospital Universitario Germans Trias i Pujol (Spain)
  • Hospital Universitario La Paz (Spain)
  • CHU UCL Hospital Mont-Godinne (Belgium)
  • Hospital Universitario Vall d’Hebron hospital network (Spain)
  • Iceland Directorate of Health (Iceland)
  • Imperial College London Health Partners (United Kingdom)
  • Medical University of Vienna and Klinik Favoriten Hospital (Austria)
  • National Institute for Infectious Diseases, “Prof. Dr. Matei Bals” (Romania)
  • National Institute of Public Health (Poland)
  • North West E-health (United Kingdom)
  • University Hospital Ghent (Belgium)
  • CHU Hospital Saint Pierre Brussels (Belgium)
  • Hospital Fran Mihaljevic Zagreb (Croatia)